Key points from article :
The EVO-NANO platform enables to grow virtual tumours and uses artificial intelligence to optimise nanoparticle designs to treat them.
Using this platform, the team simulated simple and complex tumours with cancer stem cells.
The strategy identified nanoparticle designs that were known previously, as well as potential new designs.
"In the future, creating a digital patient tumour will enable new specialised nanoparticle treatments, without the need for costly laboratory work." said Dr. Hauert, lead author from University of Bristol.
Dr. Balaz from University of Novi Sad said, "EVO-NANO is good for testing hypotheses on the efficacy of nanoparticles for various tumour scenarios."
Dr. Stillman, co-lead author from University of Bristol says “This combines computer simulations with machine learning to find new ways to treat cancer."
The study was conducted at the University of Bristol and published in the Nature journal Computational Materials.
